ProCE Banner Activity

Hot Takes on Hereditary Angioedema: Updates on Long-term Prophylaxis for Hereditary Angioedema

Conference Coverage
Slideset

This downloadable slideset reviews recent advances in long-term prophylaxis for hereditary angioedema (HAE), focusing on new clinical trial data for garadacimab and donidalorsen and the impact of social determinants on HAE management. Key findings highlight the potential of these therapies to improve quality of life while underscoring the need for equitable access to preventive care across diverse patient populations.

Released: November 20, 2024

Expiration: November 19, 2025

Share

Faculty

Marc Riedl

Marc Riedl, MD, MS

Professor of Medicine
HAE Community Endowed Chair
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief, Division of Allergy & Immunology
University of California, San Diego
San Diego, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.